CRD-A · Crawford & Co
$12.38
-0.30 (-2.37%)
At close · Oct 28
Return incl. dividend (before tax)
Market Cap
$616.32M
Shares
48.61M
Volume · Oct 28
12.52K
Avg daily vol (3M)
64.73K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$12.68
Open$12.46
Day$12.24–12.84
52W close$9.29–13.77
Avg vol 30d66K
Short int354K · 0.7% float · 7.5d
Short vol52%
Last earningsNov 3, 2026
DataJan 2020–Oct 2026
Filing10-Q · Aug 3
Up next
Next earnings release
Nov 2, 2026
Announced
· in 1 wks
Next earnings call
Nov 3, 2026
Scheduled
· in 1 wks
filed Aug 3, 2026
call held Aug 4, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$1.30B
Trailing 12 months
Net income (TTM)
$23.52M
Trailing 12 months
Revenue growth YoY
-1.4%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
12.7
Trailing earnings · reciprocal yield 7.9%
FCF yield
15.6%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$163.51M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+2.5%
Year over year · more shares
Price change (1Y)
+16.0%
Trailing year
Short interest
0.7%
Latest settlement · 7.5 days to cover
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
High
Market backdrop
VIX 17.5 · elevated
Equity put/call 0.59
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+12%
above
Price vs 50-day avg
−0%
below
RSI (14)
52
neutral
MACD trend
Positive
52-week position
76%
mid-range
Momentum
relative strength
1-month return
+1%
trailing
6-month return
+31%
trailing
YTD return
+13%
this year
Relative strength
+27%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $13 › 200d $11 — 50d above 200d
Institutional flow
Accumulating
25 of 116 funds reported for Sep 30 · net +322.5K sh shares · +4 new
Insider flow
Distributing
Net -$330.0K over 90 days · 100% sells
Short interest
Falling
0.73% of float · ▼ -21.3% MoM · 7.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
116 holders — mid 3-yr range
Squeeze score
54
elevated · 0–100
Fundamentals
Revenue growth
−4%
Y/Y
EPS growth
+124%
Y/Y
Free cash flow
$94.8M
Balance sheet
$163.5M
net debt
Quant / Vol
risk profile
Volatility
33%
annualized · 1-yr
Max drawdown
−22%
past year
ATR
4.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+12%
Bullish
Price vs 50-day avg
−0%
Neutral
RSI (14)
52
Neutral
MACD trend
Positive
Bullish
52-week position
76%
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $13 › 200d $11 — 50d above 200d
Institutional flow
Accumulating
25 of 116 funds reported for Sep 30 · net +322.5K sh shares · +4 new
Insider flow
Distributing
Net -$330.0K over 90 days · 100% sells
Short interest
Falling
0.73% of float · ▼ -21.3% MoM · 7.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
116 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $9
Now $13 · 76%
Range high $14
vs 200-day avg +12%
vs 50-day avg 0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA Margin non-GAAP | 11.7% | Q2 2026 | — |
| Adjusted Operating Margin non-GAAP | 9.2% | Q2 2026 | — |
| Broadspire cases received | 149,733 | the three months ended June 30, 2026 filing | — |
| Cases received | 151,418 | the three months ended June 30, 2026 filing | — |
| Catastrophe Services cases received | 654 | the three months ended June 30, 2026 filing | — |
| Consolidated adjusted EBITDA non-GAAP | 59.9M | six months ended June 30, 2026 | — |
| Consolidated adjusted operating earnings non-GAAP | 43.1M | six months ended June 30, 2026 | — |
| Consolidated operating earnings | 29.45M | three months ended June 30, 2026 | — |
| Contractor Connection | 24,957 | the three months ended June 30, 2026 filing | — |
| Free Cash Flow non-GAAP | 7.9M | six months ended June 30, 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net Income Attributable to Shareholders of Crawford & Company 18.35M
+20.62M Depreciation and Other Non-Cash Operating Items
+2.29M Software Impairment
+1.29M Loss on disposition of businesses, net
-180K Contingent Earnout Adjustments
-3.5M Billed Receivables Change
-16.38M Unbilled Receivables Change
-20.08M Change in Accrued Compensation, 401K, and Other Payroll
+2.44M Accounts Payable and Accrued Liabilities
+18.29M Other Working Capital Changes
-3.21M Property & Equipment Purchases, net
-12.04M Capitalized Software (internal and external costs)
= Free Cash Flow 7.9M
|
|||
| Funded Ratio of US pension plan | 94.4% | end of Q2 2026 | — |
| International Operations cases received | 151,418 | the three months ended June 30, 2026 filing | — |
| Medical Management cases received | 39,879 | the three months ended June 30, 2026 filing | — |
| Net debt non-GAAP | 128.66M | June 30, 2026 | — |
GAAP → non-GAAP reconciliationGAAP Total debt 198.08M
-69.42M Less: Cash and cash equivalents
= Net Debt 128.66M
|
|||
| New business won | 22M | the quarter | — |
| Non-GAAP Adjusted net income attributable to Crawford & Company non-GAAP | $18.79M | Three Months Ended June 30, 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net Income Attributable to Crawford & Company (GAAP) 13.45M
+1.49M Amortization of intangible assets
+1.07M Non-service pension costs
+1.09M Loss on disposition of businesses, net
+1.7M Software impairment
= Non-GAAP Adjusted Net Income Attributable to Crawford & Company 18.79M
|
|||
| Non-GAAP diluted earnings per share CRD-A non-GAAP | $0.54 | six months ended June 30, 2026 | — |
| Non-GAAP diluted earnings per share CRD-B non-GAAP | $0.54 | six months ended June 30, 2026 | — |
| Non-GAAP net income attributable to shareholders non-GAAP | 26.6M | six months ended June 30, 2026 | — |
| Operating earnings | $7.2M | the three months ended June 30, 2026 filing | — |
| Operating Earnings (Broadspire) non-GAAP | $26.59M | Six Months Ended June 30, 2026 | — |
| Operating Earnings (International Operations) non-GAAP | $14.86M | Six Months Ended June 30, 2026 | — |
| Operating Earnings (U.S. Property & Casualty) non-GAAP | $14.77M | Six Months Ended June 30, 2026 | — |
| Operating earnings of all reportable segments | 33.75M | the three months ended June 30, 2026 filing | — |
| Reimbursed expenses included in total revenues | 6.3M | the three months ended June 30, 2026 filing | — |
| Retention rate | 87.5% | Q2 2026 | — |
| Revenues before reimbursements (International Operations) | $137.95M | the three months ended June 30, 2026 filing | +4.2% |
|
|
|||
| Segment Operating Earnings (Broadspire) | 15.73M | the three months ended June 30, 2026 filing | — |
| Segment Operating Earnings (International Operations) | 10.86M | the three months ended June 30, 2026 filing | — |
| Segment Operating Earnings (U.S. Property & Casualty) | 7.16M | the three months ended June 30, 2026 filing | — |
| Segment unit volume change (cases received) | -16.5% | the three months ended June 30, 2026 filing | — |
| Shares repurchased CRD-A | 763,577 | the first six months of 2026 | — |
| Shares repurchased CRD-B | 97,940 | the first six months of 2026 | — |
| Subrogation cases received | 7,478 | the three months ended June 30, 2026 filing | — |
| Total Crawford Cases Received | 378,646 | the three months ended June 30, 2026 filing | — |
| U.S. Property & Casualty non-GAAP | $7.16M | Quarter ended June 30, 2026 | — |
| U.S. Property & Casualty cases received | 77,495 | the three months ended June 30, 2026 filing | — |
| U.S. Property & Casualty operating earnings | 7.16M | three months ended June 30, 2026 | — |
| Unallocated corporate and shared costs | $4.3M | the three months ended June 30, 2026 filing | — |
| Unallocated corporate and shared costs, net non-GAAP | -$4.3M | Quarter ended June 30, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Insurance Brokers — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CRD-A
this stock
Crawford & Co
|
$616.32M | +12.7% | -3.5% | — | 0.0% |
|
MRSH
Marsh & Mclennan Companies, Inc.
|
$90.67B | +2.8% | +10.3% | 22.8 | 1.4% |
|
AJG
Arthur J. Gallagher & Co.
|
$66.38B | +0.1% | +10.1% | 43.0 | 2.8% |
|
AON
Aon plc
|
$64.17B | -14.3% | +7.7% | 16.7 | 1.6% |
|
WTW
Willis Towers Watson PLC
|
$29.36B | -2.7% | -2.2% | 19.6 | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CRD-A | +0.9% | +0.6% | +31.4% | +1.6% | +12.7% |
| SPY | +0.1% | +0.7% | +4.9% | +0.9% | +12.9% |
| vs SPY | +0.8% | -0.1% | +26.5% | +0.7% | -0.2% |
Capital returns
Buyback program
· as of Jun 30, 2026
Authorized
shares 2.00M
Spent (derived)
shares 739,627
Remaining
shares 1.26M
Spent
Remaining
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.